Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the ...

Other research found that placebo, or fake injections ... The goal in this phase is to stick to your new eating habits and maintain weight loss long-term. hCG dietary restrictions and preferences ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for ...

Eli Lilly and Novo Nordisk, which dominate the market with their obesity injections Zepbound and Wegovy, respectively, are both looking to develop next-generation versions. A weight loss pill ...